Skip to main content

Table 4 Annual percentage change in primary drug-resistant rate of Mycobacterium tuberculosis in Shandong, China, 2004–2018

From: Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004–2018

Variables

Phases

APC

Test Statistic (t)

Prob > |t|*

Type

 DR-TB (Total)

2004–2007

−9.2(− 21.2,4.6)

−1.60

0.20

2007–2010

6.2(−20.1,41.1)

0.50

0.60

2010–2018

−0.9(−4.0,2.2)

− 0.70

0.50

 MR-TB

2004–2007

− 20.6*(− 33.7,-4.9)

−3.00

0.00

2007–2010

7.5(−25.1,54.3)

0.50

0.60

2010–2018

−0.2(−4,3.8)

− 0.10

0.90

 MDR-TB

2004–2006

57.9*(0.3148.7)

2.40

P < 0.001

2006–2010

11.4(−11.3,39.7)

1.10

0.30

2010–2018

−3.4(− 8,1.6)

−1.60

0.10

 PDR-TB

2004–2007

16.7(−17.6,65.4)

1.00

0.30

2007–2013

−3.8(− 17.7,12.4)

−0.60

0.60

2013–2018

4.1(− 10.9,21.6)

0.60

0.60

Age (years)

 15–44

2004–2010

3.8(−4.1,12.4)

1.10

0.30

2010–2014

−5.3(−25.2,19.9)

−0.50

0.60

2014–2018

8.4(− 6.6,25.8)

1.30

0.20

 45–64

2004–2007

−20.5*(−33.2,-5.3)

− 3.10

P < 0.001

2007–2010

18.1(− 16.8,67.7)

1.10

0.30

2010–2018

−3.2(−6.8,0.6)

−2.00

0.10

 > 65

2004–2009

−12.7*(−21.8,-2.4)

−2.70

0.00

2009–2018

3.3(−1.3,8.1)

1.60

0.10

Sex

 Female

2004–2008

−6.4(−39.8,45.4)

−0.30

0.70

2008–2018

1.2(−9.2,12.8)

0.20

0.80

 Male

2004–2006

−10.3(−43.5,42.5)

−0.50

0.60

2006–2018

0.4(−2.3,3.2)

0.40

0.70

Cavity

 No

2004–2006

−11.9(−55.5,74.7)

− 0.40

0.70

2006–2014

−1.3(−9.9,8.2)

−0.30

0.70

2014–2018

3.5(−16.6,28.5)

0.40

0.70

 Yes

2004–2010

3.2(−9.6,17.9)

0.50

0.60

2010–2018

−0.1(−8.3,8.9)

0.00

1.00

Smoking

 No

2008–2018

1.6(−0.5,3.8)

1.80

0.10

 Yes

2008–2011

−7.2(−41,45.9)

−0.40

0.70

2011–2018

7.1*(0.8,13.8)

2.90

P < 0.001

Drinking

 No

2008–2014

−1.2(−4.9,2.6)

−0.80

0.40

2014–2018

4.5(−2.7,12.1)

1.60

0.20

 Yes

2008–2018

6.7*(1.6,12.1)

3.00

P < 0.001

First-line drugs

 INH

2004–2018

−2.3*(−4.3,-0.3)

− 2.50

P < 0.001

 RFP

2004–2010

16.9*(5.8,29.1)

3.50

P < 0.001

2010–2018

−1.1(−7.3,5.4)

−0.40

0.70

 EMB

2004–2009

−6.9(−30.5,24.6)

−0.50

0.60

2009–2018

6(−5.9,19.4)

1.10

0.30

 SM

2004–2018

1.8(−0.7,4.4)

1.50

0.10

  1. APC Annual percent change, TB Tuberculosis, DR-TB Drug-resistant tuberculosis, MR-TB Mono-resistant tuberculosis, MDR-TB Multi-resistant tuberculosis, PDR-TB Polydrug resistant tuberculosis, EMB Ethambutol, INH Isoniazid, RFP Rifampin, SM Streptomycin
  2. *P < 0.05